Investor relations
Financial calendar
Zinzino Interim report Q3 2024
Zinzino Delårsrapport Q3 2024
Zinzino Bokslutskommuniké 2024
Zinzino Year-End Report 2024
Annualreport 2024
Årsredovisning 2024
Financial reports
Press releases
ZINZINO AB (PUBL): Share subscription due to directed set-off issues
torsdag 19. september 2024 15.30
ÅpneZINZINO AB (PUBL.): ZINZINO ACQUIRES 49% OF CYPRIOT OLIVE OIL PRODUCER CLEANTHI ALPHA-OLENIC LTD
torsdag 27. juni 2024 11.00
ÅpneZINZINO AB (PUBL): LETTER OF INTENT TO ACQUIRE ZURVITA INCREASES DISTRIBUTION POWER IN NORTH AMERICA
mandag 17. juni 2024 11.00
ÅpneZINZINO AB (PUBL): Zinzino announces Serbia as next step in its global expansion
tirsdag 11. juni 2024 15.30
ÅpneZINZINO AB (PUBL): Zinzino now seeks acquisitions in the US and Asia to increase distribution power
fredag 7. juni 2024 12.00
ÅpneZINZINO AB (PUBL): Zinzino acquires assets in Xelliss – strategic reinforcement in southern Europe and in the microalgae spirulina
søndag 12. mai 2024 13.00
ÅpneZINZINO AB (PUBL): NOTICE OF ANNUAL GENERAL MEETING IN ZINZINO AB ON MAY 27, 2024
fredag 26. april 2024 08.00
ÅpneZINZINO AB (PUBL): Zinzino and ACN, enter a strategic partnership in Europe, and in connection with it Zinzino carries out a directed new issue of B shares for SEK 10.4 million.
mandag 29. januar 2024 10.00
ÅpneZINZINO AB (PUBL): Zinzino changes Certified Adviser to Carnegie Investment Bank AB (publ)
torsdag 30. november 2023 09.00
ÅpneZINZINO AB (PUBL): Zinzino announces Mexico as next step in its global expansion
fredag 22. september 2023 08.00
ÅpneZINZINO AB (PUBL.): NOTICE TO THE ANNUAL MEETING OF ZINZINO AB ON MAY 31, 2023
tirsdag 2. mai 2023 08.00
ÅpneZINZINO AB (PUBL): Zinzino launches Turkey as a next market on their road towards global expansion
tirsdag 7. mars 2023 14.30
ÅpneGrowing interest in personal health and customized supplements can be a great investment case
mandag 28. november 2022 14.30
ÅpneZINZINO AB (PUBL): Share subscription due to directed offset issue
onsdag 26. oktober 2022 16.30
ÅpneZinzino announces the launch of Singapore as next step in their global expansion
torsdag 7. april 2022 11.30
ÅpneZINZINO AB (PUBL): Zinzino acquires brand portfolio with Swiss skincare and supplements
onsdag 6. april 2022 09.30
ÅpneZINZINO AB (PUBL): MEMBERS OF THE NOMINATION COMMITTEE FOR ZINZINO AB'S ANNUAL GENERAL MEETING IN 2022
torsdag 18. november 2021 14.00
ÅpneZINZINO AB (PUBL): Zinzino announces the launch of South Africa as next step in their global expansion
tirsdag 9. november 2021 11.30
ÅpneZINZINO AB (PUBL): Zinzino announces launch of Taiwan as next step in the global expansion
torsdag 9. september 2021 13.00
ÅpneZINZINO AB (PUBL): Zinzino announces the launch of Malaysia as next step in their global expansion
torsdag 3. juni 2021 11.00
ÅpneZINZINO AB (PUBL): A new signature BalanceOil from the pioneers of test-based nutrition
torsdag 15. april 2021 15.00
ÅpneZINZINO AB (PUBL): Zinzino announces the launch of India as next step in their global expansion strategy
tirsdag 6. april 2021 14.00
ÅpneZINZINO AB (PUBL): Further expansions of the Zinzino global web shop
tirsdag 15. desember 2020 16.15
ÅpneZINZINO AB (PUBL): ZINZINO MOVES TO THE PREMIER SEGMENT OF FIRST NORTH GROWTH MARKET
onsdag 16. september 2020 10.00
ÅpneZINZINO AB (PUBL): ONE-TIME EFFECT DUE TO CHANGED ACCOUNTING FOR DISTRIBUTOR REMUNERATION IMPROVES Q1 2020 WITH SEK 22.2 MILLION BEFORE TAX
tirsdag 5. mai 2020 12.00
ÅpneZINZINO AB (PUBL): Zinzino and Life Leadership collaborate to provide test-based nutrition to expanding markets
fredag 25. oktober 2019 16.40
ÅpneZINZINO AB (PUBL): THE BOARD DECIDES TO ISSUE 200 000 STOCK OPTIONS
mandag 15. oktober 2018 15.00
ÅpneZINZINO AB (PUBL.) APPOINTED “GROWTH COMPANY OF THE YEAR 2017” BY DIRECT SELLING SWEDEN
fredag 1. juni 2018 11.00
ÅpneZINZINO AB (PUBL): Q1; CONTINUED SOUND GROWTH AND STRONG PROFITABILITY IMPROVEMENT, EBITDA RISING BY 45%
tirsdag 15. mai 2018 08.00
ÅpneZINZINO AB (PUBL): STRONG GROWTH AND PROPOSAL FOR GREATLY INCREASED DIVIDENDS
onsdag 28. februar 2018 08.00
ÅpneZINZINO AB (PUBL): PRELIMINARY SALES REPORT FOR Q4 AND 2017 WITH PROPOSAL TO INCREASE DIVIDEND
fredag 19. januar 2018 18.00
ÅpneInterim report, July – September 2017: IMPROVED GROSS MARGINS AND STRONG GROWTH IN THE DOMESTIC MARKET.
mandag 13. november 2017 08.30
ÅpneZinzino launches groundbreaking product: BalanceOil Vegan for the heart and brain
fredag 20. oktober 2017 13.00
ÅpneZINZINO AB (PUBL): CORRECTION: PRELIMINARY SALES REPORT THIRD QUARTER 2017
tirsdag 10. oktober 2017 17.00
ÅpneInterim Report, Zinzino, April – June 2017: Very strong growth of 28% and full-scale launch of a new digital platform
torsdag 31. august 2017 09.00
ÅpneZINZINO LAUNCHES VIVA, A NEW DIETARY SUPPLEMENT PROMOTING BETTER SLEEP, REDUCING STRESS AND INCREASING WELL-BEING
fredag 30. juni 2017 15.00
ÅpneZinzino AB (publ.) appointed “Growth Company of the Year 2016” in direct sales
fredag 2. juni 2017 16.00
ÅpneZinzino begins selling in Switzerland ”Rich in capital and an important market”
tirsdag 16. mai 2017 16.00
ÅpneInterim Report, January – March 2017: Zinzino continues to deliver strong growth and is well prepared for increased profitability
onsdag 10. mai 2017 09.00
ÅpneZinzino taking the Omega-6/Omega-3 concept to new heights with water-miscible AquaX oil
torsdag 7. juli 2016 16.24
ÅpneYear-End Report 1st January - 31st December 2015, Zinzino AB (publ)
mandag 29. februar 2016 11.53
ÅpneSweden's Zinzino is improving its foothold in Europe – with the establishment of operations in Germany
mandag 22. februar 2016 08.00
ÅpneZinzino launches Zinzino LeanShake – a nutritious meal replacement for weight control
fredag 11. desember 2015 11.58
ÅpneSwedish Zinzino continues to grow internationally with its establishment in Canada
torsdag 17. september 2015 09.28
ÅpneZinzino AB (publ) acquires further 13.8 per cent of Faun Pharma AS – safeguarding continued research and expanded product range
fredag 6. mars 2015 10.29
ÅpneFinancial Statements 1 January - 31 December 2014, Zinzino AB (publ)
fredag 27. februar 2015 14.39
ÅpneThe stock
Sustainability Report
Read more about our sustainability approach, targets and 2023 performance.
Greta Billing
shares@zinzino.com
+46 73 627 17 54
Fredrik Nielsen
shares@zinzino.com
+46 (0)707 900 174
Certified Adviser
All companies whose shares are to be traded on the Nasdaq First North Premier Growth Market have a certified adviser who guides and supports the company through the listing process. Subsequently, the adviser monitors that the company complies with First North's regulations for providing information to the market and investors. Carnegie Investment Bank AB (publ) is the Certified Adviser for Zinzino AB.
Certified Adviser:
The Company’s Certified Adviser is Carnegie Investment Bank AB (publ)
Phone: +46 (0)73 856 42 65
E-mail: certifiedadviser@carnegie.se
Why invest in Zinzino
A clear global strategy with a growth-driven, future-proof business model
Zinzino is one of Europe’s fastest-growing direct sales companies with an aggressive global expansion strategy. The Scandinavian-based health tech company is currently operating in Europe, North America, Asia, Australia, India and Africa. The overall company strategy and business model is to achieve profitable growth in new as well as existing markets. The massive growth momentum of the past decade is expected to stay constant thanks to the stability and structure of the business model in combination with top-of-the-line digital market tools as well as continuous company acquisitions.
Help improve the health of the world
Our product concept is to give health back to the world. Our goal is to get the best out of people with enthusiasm, encouragement and a great deal of energy. We are the most customer-focused direct sales company in the world. Our most important product concept, Balance, is showing continued good growth and we currently have over 500,000 test results based on blood tests in our database. We are the company that has done the most fatty acid analyses in the world.
Product development at the leading edge
Through efficient product development in-house, the company has developed a number of new products in health in which it owns its own important intellectual property rights. The newly developed products are manufactured in our own efficient production facility which means that we have 100% quality control. Zinzino’s strategy in the coming years includes continued product development at the leading edge.
Strong market position and distribution
Zinzino has strong sales organisations in its principal markets with good relationships with its customer base. The broad product portfolio attracts new customer groups and thereby generates growth. Through an updated IT platform and logistics system, Zinzino is well equipped for the expected sales growth in the coming years.
Attractive cash flow enables increased stock dividends and gives a good direct return
Zinzino’s business has a very strong cash-generating capability. Effective management of working capital combined with investments that quickly generate revenue and marginal improvements generate a strong cash flow. Thus, dividends can be distributed in accordance with the target of at least 50 per cent of the free cash flow.
Del denne siden
Eller kopier lenken